Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

XY03 EA

Next Previous
X
Search
Drug Profile

XY03 EA

Alternative Names: XY03-EA

Latest Information Update: 21 Sep 2022

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Shijiazhuang Yiling Pharmaceutical
  • Class Benzofurans; Butyric acids; Esters; Ketones; Neuroprotectants; Small molecules; Vascular disorder therapies
  • Mechanism of Action Autophagy inhibitors; Oxygen radical scavengers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Stroke

Most Recent Events

  • 25 Aug 2022 Phase-I clinical trials in Stroke in China (PO) prior to August 2022 (Shijiazhuang Yiling Pharmaceutical pipeline, August 2022)
  • 25 Aug 2022 Shijiazhuang Yiling Pharmaceutical plans a phase II trial for Sroke in October 2022 (PO) (NCT05515393)
  • 30 Mar 2022 Pharmacodynamics data from a preclinical trial in Stroke released by Shijiazhuang Yiling Pharmaceutical

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top